Follow Health Care Reform Insider on Twitter
Loading...
You are here:  Home  >  Public Health  >  Current Article

Doctors Unwilling to Trust Similarity of Biosimilars

May 15, 2015 

The FDA’s approval in March of the first biosimilar drug for the US market has aroused much concern among physicians, who fear that these complex drugs will not be perfect substitutes for the branded drugs they will replace and who insist that certain standards be attached to their approval and distribution.

http://www.onclive.com/publications/oncology-business-news/2015/june-2015/doctors-unwilling-to-trust-similarity-of-biosimilars/1

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>